Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Spine J. 2016 Mar;16(3):291–298. doi: 10.1016/j.spinee.2015.08.041

Table 1.

Baseline and Treatment Characteristics

n= %

Age
median (range) 61 (33–77)
Gender
Male 4 33
Female 8 67
Primary Tumor site
Head/Neck 2 17
Abdomen/Pelvis 6 50
Extremeties 4 33
Histology
Hemangiopericytoma 2 17
Rhabdomyosarcoma 1 8
Leiomyosarcoma 6 50
Myxoid Fibrosarcoma 2 17
Myxoid Liposarcoma 1 8
KPS
80 10 83
90 2 17
Disease Extent at Spine RT Start
Single metastatic site 0 0
Disseminated spine/bone only 2 17
Bone and Visceral sites 10 83
Treated Spinal Site
Thoracic Spine 2 17
Lumbar Spine 8 67
Sacrum 2 17
RT Dose x Fraction
24 Gy x 1 7 58
9 Gy x 3 4 33
10 Gy x 3 1 8
BED
Median (range) 81.6 (51.3–81.6)
GTV Volume (cm3)
Median (range) 6.6 (1.0–46.5)
PTV Volume (cm3)
Median (range) 115.1 (7.6–203.2)
Systemic Therapy Post-RT
Yes 10 83
No 2 17